ALKBH1

Nucleic acid dioxygenase ALKBH1 · Q13686 · ALKBH1 on Sugi Atlas →

4,734 patent compounds predicted against ALKBH1, 2,111 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL358277 SCHEMBL358277 0.57 9/20
SCHEMBL4531709 SCHEMBL4531709 0.49 9/20
SCHEMBL2864450 SCHEMBL2864450 0.50 8/20
SCHEMBL4762197 SCHEMBL4762197 0.43 8/20
SCHEMBL2148413 SCHEMBL2148413 0.38 8/20
SCHEMBL2861439 SCHEMBL2861439 0.51 7/20
SCHEMBL2861126 SCHEMBL2861126 0.54 6/20
SCHEMBL2859635 SCHEMBL2859635 0.53 6/20
SCHEMBL1198990 SCHEMBL1198990 0.51 6/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL2938655) 0.47 6/20
SCHEMBL1414655 SCHEMBL1414655 0.44 6/20
SCHEMBL553831 SCHEMBL553831 0.43 6/20
SCHEMBL370482 SCHEMBL370482 0.41 6/20
SCHEMBL4022892 SCHEMBL4022892 0.38 6/20
SCHEMBL2088870 SCHEMBL2088870 0.34 6/20
SCHEMBL4703265 SCHEMBL4703265 0.51 5/20
SCHEMBL5883689 SCHEMBL5883689 0.51 5/20
SCHEMBL3753454 SCHEMBL3753454 0.47 5/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL1921639) 0.47 5/20
SCHEMBL3777154 SCHEMBL3777154 0.45 5/20

Clinical trials — most relevant to ALKBH1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients PHASE1/PHASE2COMPLETED
Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis PHASE1/PHASE2RECRUITING
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma PHASE1RECRUITING
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors PHASE1COMPLETED
Epitranscriptomic Blood Biomarkers for Coronary Artery Disease - A Prospective Cohort Study (IHD-EPITRAN) nanUNKNOWN
Expression of TET1 Gene in Acute Leukaemia nanUNKNOWN
The Molecular Pathogenesis Study of Cataract nanUNKNOWN
Investigation of the Genetic and Environmental Causes of Autism: a Multi-Center Study nanNOT_YET_RECRUITING
Investigation of ADA Enzyme Deficiency nanUNKNOWN
Prognosis of METTL-14 in Endometrial Carcinoma nanNOT_YET_RECRUITING
Molecular Profiling for Risk Stratification in Appendiceal Cancer nanRECRUITING
Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA) nanUNKNOWN
Impact Of Choline in Patients With NAFLD nanUNKNOWN
Using the Epitranscriptome to Diagnose and Treat Gliomas nanRECRUITING
Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD nanNOT_YET_RECRUITING
DNA Adductomics for Colorectal Cancer Investigation nanUNKNOWN
A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients nanCOMPLETED
Proof of Concept Creatine Supplementation for Homocystinuria Study nanACTIVE_NOT_RECRUITING
Hydroxymethylation, Incident Type 2 Diabetes and Incident Obesity nanUNKNOWN
Studying Tumor Samples From Young Patients With Neuroblastoma nanCOMPLETED
The Role of FTO Gene Polymorphism and Insulin Preparation in Obesity in Children With Type 1 Diabetes Mellitus nanCOMPLETED
ADAR1 Expression Level in Rectal Cancer nanRECRUITING
Adenosylmethionine Metabolism in Human Inflammation nanUNKNOWN
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients nanCOMPLETED
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage nanUNKNOWN
Infrared Wraps Effect on Oxygenation of Diabetics Arm, Feet and Lower Leg nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ALKBH1 binder may also engage these)

ProteinNameSimilarity
P0CB42 1.000 P0CB42 →
KDM5B Lysine-specific demethylase 5B 0.992 landscape →
KDM5D Lysine-specific demethylase 5D 0.991 landscape →
A3KGZ2 0.991 A3KGZ2 →
Q5XUN4 0.990 Q5XUN4 →
Q5F3R2 0.990 Q5F3R2 →
Q9D5Z5 0.990 Q9D5Z5 →
DHX29 ATP-dependent RNA helicase DHX29 0.990 landscape →
F4KH86 0.989 F4KH86 →
Q9D3R6 0.989 Q9D3R6 →
Q62240 0.989 Q62240 →
Q9Z2R9 0.989 Q9Z2R9 →
O60066 0.989 O60066 →
D3YWQ0 0.989 D3YWQ0 →
KDM4E Lysine-specific demethylase 4E 0.989 landscape →
A1L252 0.989 A1L252 →
Q9CQ04 0.988 Q9CQ04 →
KAT8 Histone acetyltransferase KAT8 0.988 landscape →
P0DO23 0.988 P0DO23 →
Q9LX30 0.988 Q9LX30 →
F4IF36 0.988 F4IF36 →
Q6NXH8 0.988 Q6NXH8 →
B5E0H4 0.988 B5E0H4 →
A8E7C5 0.988 A8E7C5 →
Q8BMD7 0.988 Q8BMD7 →
Q8BJM7 0.988 Q8BJM7 →
Q5I3B2 0.988 Q5I3B2 →
Q4R8E0 0.988 Q4R8E0 →
Q3T9Z9 0.988 Q3T9Z9 →
Q5E9U4 0.988 Q5E9U4 →